Medtronic (MDT) Misses Q4 EPS by 5c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase
May 26, 2022 6:46 AM EDTMid-single digit FY22 revenue growth; Q4 results affected by temporary global supply chain impacts and China lockdowns
DUBLIN, May 26, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2022, which ended April 29, 2022.
Key Highlights
FY22 revenue increased 5% reported and organicFY22 GAAP diluted EPS increased 40%; non-GAAP diluted EPS increased 26%FY22 cash flow from operations of $7.3 billion increased 18%; FY22 free cash flow of $6.0 billion increased 22%Quarterly dividend... More